EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

Autor: Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A.

Background: Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Objective: To bring together a large multidisciplinary group of ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4094::5f38d4d41e552aac8431ffc4bee13521
http://hdl.handle.net/11585/801900

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort

Autor: Antoine G. van der Heijden, Konstantinos Dimitropoulos, Joost L. Boormans, Bogdan Geavlete, Iris Brummelhuis, Andrew K. Williams, Christoph R. Müller, Susanne Vahr Lauridsen, Arturo Chiti, Manish I. Patel, Jonathan E. Rosenberg, Baris Turkbey, Carl Salembier, Thomas Wiegel, Anja Lorch, Valérie Fonteyne, Willem de Blok, Evanguelos Xylinas, Antti Salminen, Ann Henry, Karin Plass, Amir Sherif, Hugh Mostafid, Peter Wiklund, Erik Veskimäe, Hein Van Poppel, Max Bürger, Juan Palou, J. Domínguez-Escrig, Karel Decaestecker, Morgan Rouprêt, Helle Pappot, Paul Sargos, Berardino De Bari, Riccardo Valdagni, Luís Pacheco-Figueiredo, Jorge Huguet, Silke Gillessen, Olivier Rouvière, Maria J. Ribal, Yann Neuzillet, Richard Cathomas, Shaista Hafeez, Robert Jan Smeenk, Mark Frydenberg, Marek Babjuk, Antoni Vilaseca, Maria De Santis, Jonathan Richenberg, Annemarie Leliveld, Tom J.H. Arends, Shomik Sengupta, Vibeke Løgager, Harry W. Herr, Wim J.G. Oyen, Ananya Choudhury, Nicholas D. James, Susanne Osanto, Shahrokh F. Shariat, Vincent Khoo, A. Müller, Neeraj Agarwal, Pieter De Visschere, Bradley R. Pieters, Alberto Briganti, Robert Jones, Peter C. Black, Alberto Bossi, H. Maxim Bruins, Richard P. Meijer, Bertrand Tombal, Ken Herrmann, Donna E. Hansel, M. Carmen Mir, Stéphane Culine, J. Alfred Witjes, Virginia Hernández, Joaquim Bellmunt, Arnulf Stenzl, Eva Compérat, Alan Horwich, Alison Birtle, Jorg R. Oddens, Bernhard Grubmüller, Margitta Retz, Sylvain Ladoire, Marco Moschini, Aristotle Bamias, Simon J. Crabb, Michel Bolla, Theo H. van der Kwast, Steven MacLennan, Michael Rink, Anita Smits, Yohann Loriot, Estefania Linares-Espinós, James N'Dow, Theo M. de Reijke, Thomas Powles, Jurgen J. Fütterer, Arndt Hartmann, Daniel Castellano, Mesut Remzi, Paolo Gontero, Dickon Hayne, Anne E. Kiltie, Richard Zigeuner, Georgios Gakis, Franklin A. Vives Rivera, Stefano Fanti, Susanne Krege, Pedro C. Lara, Mihai Dorin Vartolomei, Ashish M. Kamat, Jan Oldenburg, Peter Hoskin, Andrea Necchi, Barbara Alicja Jereczek-Fossa, George N. Thalmann, Bernard H. Bochner, Florian Roghmann

Publikováno v: Annals of Oncology, 30(11), 1697-1727. Oxford University Press
Annals of Oncology, 30(11), 1697-1727. OXFORD UNIV PRESS
Ann Oncol
Horwich, A, Babjuk, M, Bellmunt, J, Bruins, H M, de Reijke, T M, de Santis, M, Gillessen, S, James, N, Maclennan, S, Palou, J, Powles, T, Ribal, M J, Shariat, S F, van der Kwast, T, Xylinas, E, Agarwal, N, Arends, T, Bamias, A, Birtle, A, Black, P C, Bochner, B H, Bolla, M, Boormans, J L, Bossi, A, Briganti, A, Brummelhuis, I, Burger, M, Castellano, D, Cathomas, R, Chiti, A, Choudhury, A, Compérat, E, Crabb, S, Culine, S, de Bari, B, DeBlok, W, de Visschere, P J L, Decaestecker, K, Dimitropoulos, K, Dominguez-Escrig, J L, Fanti, S, Fonteyne, V, Frydenberg, M, Futterer, J J, Gakis, G, Geavlete, B, Gontero, P, Grubmüller, B, Hafeez, S, Hansel, D E, Hartmann, A, Hayne, D, Henry, A M, Hernandez, V, Herr, H, Herrmann, K, Hoskin, P, Huguet, J, Jereczek-Fossa, B A, Jones, R, Kamat, A M, Khoo, V, Kiltie, A E, Krege, S, Ladoire, S, Lara, P C, Leliveld, A, Linares-Espinós, E, Løgager, V, Lorch, A, Loriot, Y, Meijer, R, Carmen Mir, M, Moschini, M, Mostafid, H, Müller, A C, Müller, C R, N'Dow, J, Necchi, A, Neuzillet, Y, Oddens, J R, Oldenburg, J, Osanto, S, Oyen, W J G, Pacheco-Figueiredo, L, Pappot, H, Patel, M I, Pieters, B R, Plass, K, Remzi, M, Retz, M, Richenberg, J, Rink, M, Roghmann, F, Rosenberg, J E, Rouprêt, M, Rouvière, O, Salembier, C, Salminen, A, Sargos, P, Sengupta, S, Sherif, A, Smeenk, R J, Smits, A, Stenzl, A, Thalmann, G N, Tombal, B, Turkbey, B, Vahr Lauridsen, S, Valdagni, R, van der Heijden, A G, van Poppel, H, Vartolomei, M D, Veskimäe, E, Vilaseca, A, Vives Rivera, F A, Wiegel, T, Wiklund, P, Williams, A, Zigeuner, R & Witjes, J A 2019, ' EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees ', Annals of Oncology, vol. 30, no. 11, pp. 1697-1727 . https://doi.org/10.1093/annonc/mdz296
Annals of Oncology
Annals of Oncology, 30(11), 1697. Oxford University Press
Annals of oncology, 30(11), 1697-1727. Oxford University Press
Annals of Oncology, Vol. 30, no. 11, p. 1697-17 (2019)
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Annals of Oncology, 30(11), 1697-1727. Elsevier Ltd.
Annals of Oncology, 30, 1697-1727
Annals of Oncology, 30, 11, pp. 1697-1727

Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains controversial. Background: Although guidelines exist for advanced and variant bladder cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4afd2ca4add70513cbef968e5d1d2bb4
https://research.rug.nl/en/publications/d08dc6c7-7679-406a-99a6-2df8e29515bb

Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trial.

Autor: Draulans C; Department of Oncology, KU Leuven, Leuven, Belgium. Electronic address: cedric.draulans@uzleuven.be., Haustermans K; Department of Oncology, KU Leuven, Leuven, Belgium; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Pos FJ; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Heide UA; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., De Cock L; Department of Oncology, KU Leuven, Leuven, Belgium., van der Voort van Zyp J; Department of Radiation Oncology, University Medical Center Utrecht, the Netherlands., De Boer H; Department of Radiation Oncology, University Medical Center Utrecht, the Netherlands., Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Kunze-Busch M; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Monninkhof EM; Julius Centre for Health Sciences and Primary Care, University Medical Center Utrecht, the Netherlands., De Roover R; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Isebaert S; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Kerkmeijer LGW; Department of Radiation Oncology, University Medical Center Utrecht, the Netherlands; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Oct 02; Vol. 201, pp. 110568. Date of Electronic Publication: 2024 Oct 02.

Intra-prostatic recurrences after radiotherapy with focal boost: Location and dose mapping in the FLAME trial.

Autor: Menne Guricová K; Department of Radiation Oncology, the Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Pos FJ; Department of Radiation Oncology, the Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Schoots IG; Department of Radiology, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Vogel WV; Department of Radiation Oncology, the Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., Kerkmeijer LGW; Department of Radiation Oncology, University Medical Center Utrecht, Radiation Oncology, Utrecht, the Netherlands; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Monninkhof EM; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., de Boer JCJ; Department of Radiation Oncology, University Medical Center Utrecht, Radiation Oncology, Utrecht, the Netherlands., van der Voort van Zyp JRN; Department of Radiation Oncology, University Medical Center Utrecht, Radiation Oncology, Utrecht, the Netherlands., Kunze-Busch M; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Draulans C; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., Haustermans K; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium., van Houdt PJ; Department of Radiation Oncology, the Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands., van der Heide UA; Department of Radiation Oncology, the Netherlands Cancer Institute (NKI-AVL), Amsterdam, the Netherlands. Electronic address: u.vd.heide@nki.nl.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Sep 13; Vol. 201, pp. 110535. Date of Electronic Publication: 2024 Sep 13.

Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Based Clinical Target Volume Delineation Guideline for Postprostatectomy Salvage Radiation Therapy: The PERYTON Guideline.

Autor: Staal FHE; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: f.h.e.staal@umcg.nl., Janssen J; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Oprea-Lager DE; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers - Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Engelen AM; Institute Verbeeten, Tilburg, The Netherlands., van Limbergen EJ; Department of Radiation Oncology, MAASTRO Clinic, GROW - School for Oncology and Developmental Biology, Maastricht, The Netherlands., Smeenk RJ; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., de Jong MAA; Radiotherapy Institute Friesland, Leeuwarden, The Netherlands., Budiharto TCG; Department of Radiation Oncology, Catharina Hospital, Eindhoven, The Netherlands., Jacobs I; Zuidwest Radiotherapeutisch Instituut, Vlissingen/Roosendaal, The Netherlands., Haverkort DMAD; Radiotherapiegroep, Arnhem/Deventer, The Netherlands., Brouwer CL; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Ng Wei Siang K; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Langendijk JA; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Verzijlbergen JF; Department of Radiology and Nuclear Medicine, Radboud University Medical Centre, Nijmegen, The Netherlands., de Jong IJ; Department of Urology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Noordzij W; Department of Nuclear Medicine & Molecular Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., Aluwini S; Department of Radiation Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Mar 01; Vol. 118 (3), pp. 688-696. Date of Electronic Publication: 2023 Sep 18.